Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Panobinostat in Relapsed/Refractory DLBCL
NCT01523834Phase 2Completed
- Sponsor
- Fondazione Italiana Linfomi
- Start
- Feb 2011
- Primary completion
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of panobinostat in diffuse large B-cell lymphoma (DLBCL), sponsored by Fondazione Italiana Linfomi. Started Feb 2011; status: completed.
02
Drugs
panobinostat
03
Conditions
diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on NCT01523834.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01523834.